MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Domain-Specific Cognitive Impairment in Non-Demented Parkinson’s Disease Psychosis

J. Hinkle, K. Perepezko, C. Bakker, T. Dawson, V. Johnson, Z. Mari, C. Marvel, K. Mills, A. Pantelyat, O. Pletnikova, L. Rosenthal, M. Shepard, D. Stevens, J. Troncoso, J. Wang, G. Pontone (Baltimore, MD, USA)

Meeting: 2017 International Congress

Abstract Number: 1082

Keywords: Cognitive dysfunction, Psychosis

Session Information

Date: Wednesday, June 7, 2017

Session Title: Parkinson's Disease: Psychiatric Manifestations

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: Our objective was to determine whether psychosis in non-demented Parkinson’s disease (PD) patients is associated with domain-specific cognitive impairment on the Mini-Mental State Exam (MMSE).

Background: Cognitive impairment, an important and common complication of PD, has been associated with the presence of psychosis. Identifying the cognitive domains impaired among PD patients with psychosis is critical for understanding the pathophysiology of psychosis and may help guide treatment strategies.

Methods: We analyzed data from 137 patients enrolled in the Morris K. Udall Parkinson’s Disease Research Center of Excellence Longitudinal Study at Johns Hopkins University.Psychosis diagnoses were established by psychiatrist interview per DSM-IV criteria. Visits where patients were diagnosed with dementia were excluded from analysis. We used generalized estimated equations (GEE) to model the relationship between MMSE subscale scores and psychosis, adjusting for potential confounding variables identified through univariate analysis.

Results: Nineteen patients in our non-demented sample (13.9%) were diagnosed with psychosis at baseline and the cumulative prevalence of psychosis among non-demented patients in the study was 22.6% (31 patients). In univariate analyses of patients at baseline, disease duration (p = 0.042) and scores on the language (p < 0.001) and intersecting pentagon (p = 0.006) MMSE subscales were significantly associated with psychosis. In multivariate GEE analyses, psychosis was significantly associated with lower scores on the orientation (odds ratio: 0.73; 95% CI: 0.58-0.93; p = 0.011), language (odds ratio: 0.64; 95% CI: 0.48-0.86; p = 0.003), and intersecting pentagon (odds ratio: 0.43; 95% CI: 0.20-0.92 p = 0.030) subscales of the MMSE.

Conclusions: In PD, executive dysfunction, disorientation, and impaired language comprehension are associated with increased odds of psychosis, which could suggest cortical co-localization of these symptoms. Domain specific cognitive deficits assessed using the MMSE may be clinically useful for identifying PD patients at elevated risk for psychosis.

To cite this abstract in AMA style:

J. Hinkle, K. Perepezko, C. Bakker, T. Dawson, V. Johnson, Z. Mari, C. Marvel, K. Mills, A. Pantelyat, O. Pletnikova, L. Rosenthal, M. Shepard, D. Stevens, J. Troncoso, J. Wang, G. Pontone. Domain-Specific Cognitive Impairment in Non-Demented Parkinson’s Disease Psychosis [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/domain-specific-cognitive-impairment-in-non-demented-parkinsons-disease-psychosis/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/domain-specific-cognitive-impairment-in-non-demented-parkinsons-disease-psychosis/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley